SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001144204-17-005140
Filing Date
2017-01-31
Accepted
2017-01-31 17:10:04
Documents
1
Group Members
CORA MADSENFLORIAN SCHONHARTINGNB PUBLIC EQUITY KOMPLEMENTAR APS

Document Format Files

Seq Description Document Type Size
1 SC 13G/A v457513_sc13g-a.htm SC 13G/A 70996
  Complete submission text file 0001144204-17-005140.txt   72654
Mailing Address 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121
Business Address 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121 2062827100
CTI BIOPHARMA CORP (Subject) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-48459 | Film No.: 17562021
SIC: 2834 Pharmaceutical Preparations

Mailing Address OESTERGADE 24A,1 DK-1100 COPENHAGEN G7 -----
Business Address OESTERGADE 24A,1 DK-1100 COPENHAGEN G7 ----- 45 70 20 12 63
NB Public Equity K/S (Filed by) CIK: 0001451330 (see all company filings)

IRS No.: 000000000
Type: SC 13G/A